Today: 21 May 2026
DroneShield stock cools after JPMorgan drops below 5% stake — what ASX:DRO investors watch next
7 January 2026
1 min read

DroneShield stock cools after JPMorgan drops below 5% stake — what ASX:DRO investors watch next

Sydney, Jan 7, 2026, 17:33 AEDT — After-hours

DroneShield Ltd (ASX:DRO) shares slipped 0.77% on Wednesday to close at A$3.89, after jumping 18.43% a session earlier on a burst of trading. Volume fell to 16.89 million shares from 32.94 million on Tuesday, and the stock traded between A$3.76 and A$3.99.

The move puts focus back on ownership and execution for the volatile defence-technology name, which has been swinging sharply session-to-session. Investors are watching whether the company can translate rising demand into steadier results, while disclosures on big holders can add to the noise.

A filing showed JPMorgan Chase & Co and its affiliates ceased to be a substantial holder in DroneShield on Jan. 2, meaning it fell below the 5% threshold that triggers disclosure in Australia. The notice cited changes linked to securities lending and collateral, and flagged trading by J.P. Morgan Securities Australia around year-end.

DroneShield earlier on Wednesday said it renewed support for the Australian Defence Force Drone Racing Team for 2026, extending a partnership it said includes sharing expertise beyond sponsorship. Chief executive Oleg Vornik said the collaboration is “about building the skills and technologies” for the next generation of defence capability, while team president Wing Commander Keirin Joyce said it creates “a unique environment for testing, learning” and advancing operational edge. DroneShield

On Tuesday, the company promoted Louis Gamarra to chief commercial officer, tasking him with leading global sales strategy and the distributor network. Vornik said strong commercial leadership is critical “to turning demand into sustained performance,” while Gamarra said he was stepping into the role at “this pivotal time” for DroneShield. DroneShield

DroneShield makes detection and electronic-warfare tools designed to spot and disrupt drones, also called counter-UAS for counter-uncrewed aerial systems. The company sells to military, government and critical-infrastructure customers, where small drones have become a growing security problem.

But the stock’s speed cuts both ways. Small-cap defence names can react sharply to contract timing, budget headlines and shifts in institutional positioning, and any stumble in execution could test support after the recent run-up.

Stock Market Today

  • Nvidia (NVDA) Reports Strong Q1 2026 with Revenue Surging 85% and Robust Guidance
    May 20, 2026, 6:31 PM EDT. Nvidia (NASDAQ:NVDA) delivered an 85.2% year-on-year revenue increase to $81.62 billion in Q1 CY2026, beating analyst expectations by 3.5%. Its adjusted earnings per share of $1.87 also surpassed forecasts by 5.4%. The company's non-GAAP EBITDA margin rose to 69.2%, supported by operating margins climbing to 65.6% from 49.1% a year ago. Nvidia provided Q2 revenue guidance of $91 billion, 5.7% above consensus, signaling accelerating demand amid growth in AI infrastructure. CEO Jensen Huang highlighted the rapid expansion of AI factories as a key growth driver. The firm's five-year compounded annual revenue growth rate sits at 67.4%, with recent acceleration reflecting strong market positioning in semiconductors, despite cyclical industry risks.

Latest articles

EnerSys Stock Just Reversed After Earnings—The Guidance Beat Traders Wanted

EnerSys Stock Just Reversed After Earnings—The Guidance Beat Traders Wanted

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus
Previous Story

Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Next Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

Go toTop